Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
- COVID-19, ECMO
Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients
- "CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization"
Dr. Phillip Chan, MD, PhD, CEO CytoSorbents Corporation - “Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb”
Mr. Stefan Sajgo, Ulm University, Ulm Germany
Share
|
Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
- October 11, 2020
- COVID-19, ECMO
Share
|
Rationale and Practical use of CytoSorb, an Extracorporeal Cytokine Adsorber, with ECMO to Treat Cytokine Storm in Critically-Ill COVID-19 patients
- "CytoSorb and ECMO: A Novel "Lung Resting" Strategy in Critically-Ill COVID-19 patients under FDA Emergency Use Authorization"
Dr. Phillip Chan, MD, PhD, CEO CytoSorbents Corporation - “Practical Experience in Treatment of COVID-19 Patients in Combination with ECMO and CytoSorb”
Mr. Stefan Sajgo, Ulm University, Ulm Germany
More Videos
Joint Perfusion COVID-19 Task Force Webinar 5: COVID-19 Treatment and Reopenings
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar